CERE
Macquarie Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,285
| Closed | -$175K | – | 1974 |
|
|
2024
Q2 | $175K | Buy |
+4,285
| New | +$175K | ﹤0.01% | 1565 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2440 |
|
|
2022
Q3 | – | Sell |
-665
| Closed | -$18K | – | 2215 |
|
|
2022
Q2 | $18K | Hold |
665
| – | – | ﹤0.01% | 2345 |
|
|
2022
Q1 | $23 | Hold |
665
| – | – | ﹤0.01% | 2355 |
|
|
2021
Q4 | $22K | Buy |
+665
| New | +$22K | ﹤0.01% | 2378 |
|